Back to Network
4
Shared Docs
4
Same-Page
4 / 4
Mentions
Document Mentions (4 shared documents)
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
isms. We just published papers and patents on this. Lead by Dan Mandell. EFTA00631419 5) Eliminating ecosystem pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
resistant organisms. We just published papers and patents on this. Lead by Dan Mandell. 5) Eliminating ecosystem pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
resistant organisms. We just published papers and patents on this. Lead by Dan Mandell. 5) Eliminating ecosystem pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing
Sponsored
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
resistant organisms. We just published papers and patents on this. Lead by Dan Mandell. 5) Eliminating ecosystem pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing
Sponsored
Mutual Connections (18)
Entities connected to both Amyris and Kevin Esvelt
Jeffrey Epstein
PERSON7 w/ Amyris·54 w/ Kevin
Marc Rich
PERSON7 w/ Amyris·5 w/ Kevin
Justin Trudeau
PERSON4 w/ Amyris·5 w/ Kevin
JC
James Clement
PERSON4 w/ Amyris·4 w/ Kevin
PM
Prashant Mali
PERSON4 w/ Amyris·4 w/ Kevin
Eric Trump
PERSON3 w/ Amyris·5 w/ Kevin
Robert Gates
PERSON4 w/ Amyris·4 w/ Kevin
TW
Ting Wu
PERSON4 w/ Amyris·4 w/ Kevin
MM
Margo Monroe
PERSON4 w/ Amyris·4 w/ Kevin
JQ
Justin Quinn
PERSON4 w/ Amyris·4 w/ Kevin
Space Genetics
ORGANIZATION4 w/ Amyris·4 w/ Kevin
DM
Dan Mandell
PERSON4 w/ Amyris·4 w/ Kevin
BD
Bobby Dhadwar
PERSON4 w/ Amyris·4 w/ Kevin
RT
Rich Terry
PERSON4 w/ Amyris·4 w/ Kevin
LY
Luhan Yang
PERSON3 w/ Amyris·3 w/ Kevin
ES
Eswar
PERSON3 w/ Amyris·3 w/ Kevin
the American Bison
ORGANIZATION3 w/ Amyris·3 w/ Kevin
HE
Helicos
PERSON2 w/ Amyris·2 w/ Kevin